Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/29959
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Meade, Julie | - |
dc.contributor.author | Gül, Zülfiye | - |
dc.contributor.author | Bağdaş, Deniz | - |
dc.date.accessioned | 2022-12-19T12:11:21Z | - |
dc.date.available | 2022-12-19T12:11:21Z | - |
dc.date.issued | 2020 | - |
dc.identifier.citation | Bağdaş, D. vd. (2020). "Pharmacologic overview of chlorogenic acid and its metabolites in chronic pain and inflammation". Current Neuropharmacology, 18(3), 216-228. | en_US |
dc.identifier.issn | 1570-159X | - |
dc.identifier.issn | 1875-6190 | - |
dc.identifier.uri | https://doi.org/10.2174/1570159X17666191021111809 | - |
dc.identifier.uri | http://www.eurekaselect.com/article/101699 | - |
dc.identifier.uri | http://hdl.handle.net/11452/29959 | - |
dc.description.abstract | Background: Natural phenolic compounds in medicinal herbs and dietary plants are antioxidants which play therapeutic or preventive roles in different pathological situations, such as oxidative stress and inflammation. One of the most studied phenolic compounds in the last decade is chlorogenic acid (CGA), which is a potent antioxidant found in certain foods and drinks. Objective: This review focuses on the anti-inflammatory and antinociceptive bioactivities of CGA, and the putative mechanisms of action are described. Ethnopharmacological reports related to these bioactivities are also reviewed. Materials and Methods: An electronic literature search was conducted by authors up to October 2019. Original articles were selected. Results: CGA has been shown to reduce inflammation and modulate inflammatory and neuropathic pain in animal models. Conclusion: The consensus of the literature search was that systemic CGA may facilitate pain management via bolstering antioxidant defenses against inflammatory insults. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Bentham Science | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.rights | Atıf Gayri Ticari Türetilemez 4.0 Uluslararası | tr_TR |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject | Chlorogenic | en_US |
dc.subject | Acid | en_US |
dc.subject | Inflammation | en_US |
dc.subject | Pain | en_US |
dc.subject | Inflammatory | en_US |
dc.subject | Neuropathic | en_US |
dc.subject | Antihyperalgesic | en_US |
dc.subject | Antiallodynic | en_US |
dc.subject | NF-Kappa B | en_US |
dc.subject | Gated potassium channels | en_US |
dc.subject | Gaba receptor agonists | en_US |
dc.subject | Nitric-oxide synthase | en_US |
dc.subject | Incuded liver-injury | tr_TR |
dc.subject | Oxygen species ros | en_US |
dc.subject | Hypericum-perforatum | en_US |
dc.subject | Caffeic acid | en_US |
dc.subject | Neuropathic pain | en_US |
dc.subject | In-vitro | en_US |
dc.subject | Neurosciences & neurology | en_US |
dc.subject | Pharmacology & pharmacy | en_US |
dc.subject.mesh | Analgesics | en_US |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Anti-inflammatory agents | en_US |
dc.subject.mesh | Chlorogenic acid | en_US |
dc.subject.mesh | Chronic pain | en_US |
dc.subject.mesh | Disease models | en_US |
dc.subject.mesh | Animal | en_US |
dc.subject.mesh | Encephalitis | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Plant extracts | en_US |
dc.subject.mesh | Sepsis | en_US |
dc.title | Pharmacologic overview of chlorogenic acid and its metabolites in chronic pain and inflammation | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000514651000004 | tr_TR |
dc.identifier.scopus | 2-s2.0-85079435812 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Bursa Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Farmakoloji Anabilim Dalı. | tr_TR |
dc.contributor.department | Bursa Uludağ Üniversitesi/Fen-Edebiyat Fakültesi/Biyoloji Anabilim Dalı. | tr_TR |
dc.contributor.orcid | 0000-0002-3595-6286 | tr_TR |
dc.identifier.startpage | 216 | tr_TR |
dc.identifier.endpage | 228 | tr_TR |
dc.identifier.volume | 18 | tr_TR |
dc.identifier.issue | 3 | tr_TR |
dc.relation.journal | Current Neuropharmacology | en_US |
dc.contributor.buuauthor | Cam, Betül | - |
dc.contributor.buuauthor | Cinkılıç, Nilüfer | - |
dc.contributor.buuauthor | Gürün, Mine Sibel | - |
dc.contributor.researcherid | AAH-5296-2021 | tr_TR |
dc.contributor.researcherid | CGO-3719-2022 | tr_TR |
dc.contributor.researcherid | DVX-8040-2022 | tr_TR |
dc.relation.collaboration | Yurt dışı | tr_TR |
dc.relation.collaboration | Yurt içi | tr_TR |
dc.identifier.pubmed | 31631820 | tr_TR |
dc.subject.wos | Neurosciences | en_US |
dc.subject.wos | Pharmacology & pharmacy | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | PubMed | en_US |
dc.wos.quartile | Q1 | en_US |
dc.contributor.scopusid | 56427863700 | tr_TR |
dc.contributor.scopusid | 26533892300 | tr_TR |
dc.contributor.scopusid | 55664349700 | tr_TR |
dc.subject.scopus | Antioxidant; Carlina Oxide; Lonicera | en_US |
dc.subject.emtree | Antioxidant | en_US |
dc.subject.emtree | Bidens pilosa extract | en_US |
dc.subject.emtree | Caffeic acid | tr_TR |
dc.subject.emtree | Cheilanthes farinose extract | en_US |
dc.subject.emtree | Chlorogenic acid | en_US |
dc.subject.emtree | Chlorogenic acid derivative | en_US |
dc.subject.emtree | Cnidium officinale extract | en_US |
dc.subject.emtree | Drug metabolite | en_US |
dc.subject.emtree | Erycibe obtusifolia extract | en_US |
dc.subject.emtree | Ferulic acid | en_US |
dc.subject.emtree | Hypericum perforatum extract | en_US |
dc.subject.emtree | Ion channel | en_US |
dc.subject.emtree | Mansoa alliacea extract | en_US |
dc.subject.emtree | Plant extract | en_US |
dc.subject.emtree | Porana sinensis extract | en_US |
dc.subject.emtree | Rosae multiflorae extract | en_US |
dc.subject.emtree | Unclassified drug | en_US |
dc.subject.emtree | Urtica circularis extract | en_US |
dc.subject.emtree | Analgesic agent | en_US |
dc.subject.emtree | Antiinflammatory agent | en_US |
dc.subject.emtree | Chlorogenic acid | en_US |
dc.subject.emtree | Plant extract | en_US |
dc.subject.emtree | Antiinflammatory activity | en_US |
dc.subject.emtree | Antinociception | en_US |
dc.subject.emtree | Arthritis | en_US |
dc.subject.emtree | Chronic pain | en_US |
dc.subject.emtree | Consensus | en_US |
dc.subject.emtree | Degenerative disease | en_US |
dc.subject.emtree | Disease model | en_US |
dc.subject.emtree | Drug mechanism | en_US |
dc.subject.emtree | Ethnopharmacology | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | In vivo study | en_US |
dc.subject.emtree | Inflammation | en_US |
dc.subject.emtree | Inflammatory pain | en_US |
dc.subject.emtree | Neuropathic pain | en_US |
dc.subject.emtree | Nonhuman | en_US |
dc.subject.emtree | Pain | en_US |
dc.subject.emtree | Review | en_US |
dc.subject.emtree | Rheumatoid arthritis | en_US |
dc.subject.emtree | Animal | en_US |
dc.subject.emtree | Chronic pain | en_US |
dc.subject.emtree | Complication | en_US |
dc.subject.emtree | Encephalitis | en_US |
dc.subject.emtree | Metabolism | en_US |
dc.subject.emtree | Sepsis | en_US |
Appears in Collections: | PubMed Scopus Web of Science |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Cam_vd_2020.pdf | 1.41 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License